Phase 2a randomized, double-blind, vehicle-controlled, intra-individual comparison trial assessing safety, toleration, pharmacokinetics and pilot efficacy of 4 weeks treatment with topical CP-690,550 in chronic plaque psoriasis

Trial Profile

Phase 2a randomized, double-blind, vehicle-controlled, intra-individual comparison trial assessing safety, toleration, pharmacokinetics and pilot efficacy of 4 weeks treatment with topical CP-690,550 in chronic plaque psoriasis

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2009

At a glance

  • Drugs Tofacitinib (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Oct 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top